Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442
Patient Information Leaflet last updated on the eMC: 28/10/2009
PIL Miacalcic 50 IU/ml and 100 IU/ml Ampoules and 400 IU/2ml Solution for Injection and Infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/10/2009 and displayed until Current
Reasons for adding or updating:
  • Individual presentations superseded by joint PIL
  • Change due to user-testing of patient information
Updated on 13/02/2009 and displayed until 28/10/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 25/04/2008 and displayed until 13/02/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 11/12/2007 and displayed until 25/04/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   calcitonin (salmon)


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk